Inlyta 5 mg (Axitinib Tablet) 3mg

Inlyta 5 mg (Axitinib) is a prescription tablet used for cancer treatment support. This targeted therapy helps manage certain types of tumors. Always consult a healthcare provider for proper use. Store at room temperature away from moisture.

Strength

3mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

Pfizer Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Inlyta 5 mg (Axitinib) is a kinase inhibitor prescribed to treat advanced renal cell carcinoma, a type of kidney cancer. It works by slowing tumor growth and is often used when other treatments have not been effective. Patients may also hear it described as a targeted therapy for solid tumors.

Side Effects

Inlyta 5 mg (Axitinib) may help reduce tumor size or slow its progression in some patients. Common effects include changes in blood pressure or digestive discomfort. Individual responses vary, and regular monitoring is recommended during treatment.

Precautions & Warnings

Keep Inlyta 5 mg (Axitinib) in its original packaging at room temperature. Protect it from heat, moisture, and direct light. Always handle with clean, dry hands and store out of reach of children and pets. Do not remove tablets from the blister pack until ready to use.

Avoid Interactions

Inlyta 5 mg (Axitinib) may interact with certain medications, including strong CYP3A4 inhibitors or inducers. Avoid grapefruit products while taking this medication. Discuss all current prescriptions and supplements with your healthcare provider before starting treatment.

Frequently Asked Questions

Inlyta 5 mg (Axitinib) is used to treat advanced renal cell carcinoma, a type of kidney cancer.

Store Inlyta 5 mg at room temperature in a dry place, away from light and moisture.

Avoid grapefruit and grapefruit juice while taking Inlyta 5 mg.

If you miss a dose, contact your healthcare provider for guidance; do not take a double dose.

Common effects may include changes in blood pressure or digestive discomfort; discuss any concerns with your doctor.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.